| Value | ₹145.0 Cr |
|---|
NSE filing, NSE: ORICONENT. Summary written from the filing by ALFA Finder's alert engine.
Oricon Enterprises Ltd: key numbers
- Share price
- ₹56.37
- Market cap
- ₹885.3 Cr
- Revenue (annual)
- ₹42.15 Cr
- Net profit (annual)
- ₹25.75 Cr
- P/E (TTM)
- 30.6×Sector 45.2×
- Promoter holding
- 65.70%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Oricon Enterprises Ltd
All →Oricon Enterprises Merger & Restructuring
Oricon Enterprises' board approved the sale of its Worli, Mumbai land (3,511.74 sq.mtrs) and building. Financial details will be disclosed upon execution of the sale agreement.
Oricon Enterprises Board Meeting Date
Oricon Enterprises has scheduled a Board Meeting on November 4, 2026 to consider Q1 FY27 financial results. The trading window will reopen 48 hours post-results.
Oricon Enterprises Other Announcement
Oricon Enterprises Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations. This is a routine disclosure.
Oricon Enterprises Promoter Selling
Sarvamangal Mercantile Company Limited, a promoter group entity, sold 9,70,000 shares (0.62%) of Oricon Enterprises Limited via open market sale. Its stake decreased from 2.30% to 1.68%.
Oricon Enterprises Promoter Buying
Promoter Mridula Somani acquired 9,70,000 equity shares (0.61% stake) of Oricon Enterprises Limited through an open market transaction on September 29, 2026.
- Promoter stake change
- +0.61%
Oricon Enterprises Annual General Meeting
Oricon Enterprises Limited conducted its 56th Annual General Meeting on September 29, 2026. Key agenda items included the adoption of financial statements and the declaration of dividend.
Other merger & restructuring announcements
All →Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹0 Cr
Sale of 26% stake in subsidiary Clean Max Alps to Bayer Vapi for ₹0.0026 Crore. The subsidiary contributed no revenue or net worth last financial year.
- Value
- ₹0.00 Cr
Vimta Labs Merger & Restructuring Worth ₹0.08 Cr
Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.
- Value
- ₹0.08 Cr
Weagro Merger & Restructuring Worth ₹0.01 Cr
Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.
- Value
- ₹0.01 Cr
- Execution
- Within two months from the date of the Board decision, subject to statutory approvals.
Tejassvi Aaharam Merger & Restructuring
Tejassvi Aaharam (now WEAGRO) approved a wholly-owned subsidiary in Singapore and a Dubai branch office. The initial investment is up to SGD 100,000.
- Execution
- Within two months from the board decision, subject to statutory approvals
Ginni Filaments Merger & Restructuring
Ginni Filaments incorporated a wholly owned subsidiary, Ginni RSA (Pty) Ltd, in South Africa. The subsidiary will trade and distribute wet wipes internationally.
Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
- Value
- ₹141.4 Cr